Logo image of BX

BLACKSTONE INC (BX) Stock Fundamental Analysis

NYSE:BX - New York Stock Exchange, Inc. - US09260D1072 - Common Stock

181.165  -0.36 (-0.2%)

Fundamental Rating

5

BX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 224 industry peers in the Capital Markets industry. BX has an average financial health and profitability rating. BX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

BX had positive earnings in the past year.
In the past year BX had a positive cash flow from operations.
Each year in the past 5 years BX has been profitable.
In the past 5 years BX always reported a positive cash flow from operatings.
BX Yearly Net Income VS EBIT VS OCF VS FCFBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B

1.2 Ratios

BX has a better Return On Assets (5.22%) than 72.15% of its industry peers.
Looking at the Return On Equity, with a value of 31.74%, BX belongs to the top of the industry, outperforming 97.72% of the companies in the same industry.
With an excellent Return On Invested Capital value of 15.68%, BX belongs to the best of the industry, outperforming 93.15% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BX is significantly above the industry average of 6.66%.
Industry RankSector Rank
ROA 5.22%
ROE 31.74%
ROIC 15.68%
ROA(3y)7.26%
ROA(5y)6.41%
ROE(3y)35.13%
ROE(5y)30.07%
ROIC(3y)19.39%
ROIC(5y)16.24%
BX Yearly ROA, ROE, ROICBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

1.3 Margins

BX has a Profit Margin of 19.46%. This is comparable to the rest of the industry: BX outperforms 53.88% of its industry peers.
In the last couple of years the Profit Margin of BX has declined.
BX's Operating Margin of 49.06% is amongst the best of the industry. BX outperforms 83.11% of its industry peers.
BX's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 49.06%
PM (TTM) 19.46%
GM N/A
OM growth 3Y-1.78%
OM growth 5Y-3.22%
PM growth 3Y0.41%
PM growth 5Y-5.14%
GM growth 3YN/A
GM growth 5YN/A
BX Yearly Profit, Operating, Gross MarginsBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

BX has more shares outstanding than it did 1 year ago.
BX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BX has been reduced compared to a year ago.
BX Yearly Shares OutstandingBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
BX Yearly Total Debt VS Total AssetsBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

2.2 Solvency

BX has an Altman-Z score of 4.33. This indicates that BX is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.33, BX belongs to the best of the industry, outperforming 83.56% of the companies in the same industry.
The Debt to FCF ratio of BX is 2.60, which is a good value as it means it would take BX, 2.60 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.60, BX belongs to the best of the industry, outperforming 82.65% of the companies in the same industry.
A Debt/Equity ratio of 1.53 is on the high side and indicates that BX has dependencies on debt financing.
BX has a worse Debt to Equity ratio (1.53) than 71.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.53
Debt/FCF 2.6
Altman-Z 4.33
ROIC/WACCN/A
WACCN/A
BX Yearly LT Debt VS Equity VS FCFBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B

2.3 Liquidity

BX has a Current Ratio of 0.67. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.67, BX is not doing good in the industry: 67.12% of the companies in the same industry are doing better.
BX has a Quick Ratio of 0.67. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
BX has a worse Quick ratio (0.67) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.67
BX Yearly Current Assets VS Current LiabilitesBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

More info and screens

6

3. Growth

3.1 Past

BX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.84%.
The Earnings Per Share has been growing by 10.85% on average over the past years. This is quite good.
BX shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.42%.
The Revenue has been growing slightly by 3.26% on average over the past years.
EPS 1Y (TTM)3.84%
EPS 3Y14.23%
EPS 5Y10.85%
EPS Q2Q%7.45%
Revenue 1Y (TTM)35.42%
Revenue growth 3Y9.55%
Revenue growth 5Y3.26%
Sales Q2Q%4.83%

3.2 Future

The Earnings Per Share is expected to grow by 14.57% on average over the next years. This is quite good.
The Revenue is expected to grow by 17.18% on average over the next years. This is quite good.
EPS Next Y14.34%
EPS Next 2Y23.46%
EPS Next 3Y22.29%
EPS Next 5Y14.57%
Revenue Next Year16.21%
Revenue Next 2Y22.69%
Revenue Next 3Y20.14%
Revenue Next 5Y17.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BX Yearly Revenue VS EstimatesBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
BX Yearly EPS VS EstimatesBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 44.62 indicates a quite expensive valuation of BX.
BX's Price/Earnings ratio is a bit more expensive when compared to the industry. BX is more expensive than 78.54% of the companies in the same industry.
When comparing the Price/Earnings ratio of BX to the average of the S&P500 Index (28.29), we can say BX is valued expensively.
Based on the Price/Forward Earnings ratio of 30.09, the valuation of BX can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BX indicates a slightly more expensive valuation: BX is more expensive than 73.97% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.44, BX is valued a bit more expensive.
Industry RankSector Rank
PE 44.62
Fwd PE 30.09
BX Price Earnings VS Forward Price EarningsBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

BX's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BX indicates a slightly more expensive valuation: BX is more expensive than 60.73% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 53.14
EV/EBITDA 40.46
BX Per share dataBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BX may justify a higher PE ratio.
A more expensive valuation may be justified as BX's earnings are expected to grow with 22.29% in the coming years.
PEG (NY)3.11
PEG (5Y)4.11
EPS Next 2Y23.46%
EPS Next 3Y22.29%

More info and screens

3

5. Dividend

5.1 Amount

BX has a Yearly Dividend Yield of 1.95%.
BX's Dividend Yield is slightly below the industry average, which is at 9.45.
Compared to an average S&P500 Dividend Yield of 2.28, BX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.95%

5.2 History

The dividend of BX has a limited annual growth rate of 5.34%.
BX has paid a dividend for at least 10 years, which is a reliable track record.
BX has decreased its dividend recently.
Dividend Growth(5Y)5.34%
Div Incr Years1
Div Non Decr Years1
BX Yearly Dividends per shareBX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4

5.3 Sustainability

196.69% of the earnings are spent on dividend by BX. This is not a sustainable payout ratio.
The dividend of BX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP196.69%
EPS Next 2Y23.46%
EPS Next 3Y22.29%
BX Yearly Income VS Free CF VS DividendBX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B
BX Dividend Payout.BX Dividend Payout, showing the Payout Ratio.BX Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKSTONE INC

NYSE:BX (1/22/2025, 10:33:08 AM)

181.165

-0.36 (-0.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-17 2024-10-17/bmo
Earnings (Next)01-30 2025-01-30/amc
Inst Owners69.97%
Inst Owner Change-0.74%
Ins Owners0.77%
Ins Owner Change0.72%
Market Cap219.73B
Analysts73.13
Price Target182.63 (0.81%)
Short Float %1.86%
Short Ratio4.03
Dividend
Industry RankSector Rank
Dividend Yield 1.95%
Yearly Dividend5.97
Dividend Growth(5Y)5.34%
DP196.69%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.58%
Min EPS beat(2)-5.35%
Max EPS beat(2)6.51%
EPS beat(4)2
Avg EPS beat(4)3.32%
Min EPS beat(4)-5.35%
Max EPS beat(4)13.42%
EPS beat(8)3
Avg EPS beat(8)1.23%
EPS beat(12)7
Avg EPS beat(12)6.41%
EPS beat(16)11
Avg EPS beat(16)10.17%
Revenue beat(2)0
Avg Revenue beat(2)-4.28%
Min Revenue beat(2)-6.69%
Max Revenue beat(2)-1.86%
Revenue beat(4)0
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-6.69%
Max Revenue beat(4)-0.38%
Revenue beat(8)0
Avg Revenue beat(8)-14.6%
Revenue beat(12)2
Avg Revenue beat(12)-5.64%
Revenue beat(16)6
Avg Revenue beat(16)34.07%
PT rev (1m)4.97%
PT rev (3m)29.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.58%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)-4.06%
Valuation
Industry RankSector Rank
PE 44.62
Fwd PE 30.09
P/S 19.22
P/FCF 53.14
P/OCF 52.12
P/B 31.36
P/tB 44.45
EV/EBITDA 40.46
EPS(TTM)4.06
EY2.24%
EPS(NY)6.02
Fwd EY3.32%
FCF(TTM)3.41
FCFY1.88%
OCF(TTM)3.48
OCFY1.92%
SpS9.43
BVpS5.78
TBVpS4.08
PEG (NY)3.11
PEG (5Y)4.11
Profitability
Industry RankSector Rank
ROA 5.22%
ROE 31.74%
ROCE 18.56%
ROIC 15.68%
ROICexc 17.12%
ROICexgc 18.62%
OM 49.06%
PM (TTM) 19.46%
GM N/A
FCFM 36.17%
ROA(3y)7.26%
ROA(5y)6.41%
ROE(3y)35.13%
ROE(5y)30.07%
ROIC(3y)19.39%
ROIC(5y)16.24%
ROICexc(3y)21.38%
ROICexc(5y)17.93%
ROICexgc(3y)23.38%
ROICexgc(5y)19.79%
ROCE(3y)23.01%
ROCE(5y)19.29%
ROICexcg growth 3Y-5.95%
ROICexcg growth 5Y-4.36%
ROICexc growth 3Y-4.42%
ROICexc growth 5Y-3.85%
OM growth 3Y-1.78%
OM growth 5Y-3.22%
PM growth 3Y0.41%
PM growth 5Y-5.14%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 1.53
Debt/FCF 2.6
Debt/EBITDA 1.9
Cap/Depr 225.1%
Cap/Sales 0.71%
Interest Coverage 14.85
Cash Conversion 74.69%
Profit Quality 185.9%
Current Ratio 0.67
Quick Ratio 0.67
Altman-Z 4.33
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)332.12%
Cap/Depr(5y)247.68%
Cap/Sales(3y)1.95%
Cap/Sales(5y)1.7%
Profit Quality(3y)230.51%
Profit Quality(5y)191.78%
High Growth Momentum
Growth
EPS 1Y (TTM)3.84%
EPS 3Y14.23%
EPS 5Y10.85%
EPS Q2Q%7.45%
EPS Next Y14.34%
EPS Next 2Y23.46%
EPS Next 3Y22.29%
EPS Next 5Y14.57%
Revenue 1Y (TTM)35.42%
Revenue growth 3Y9.55%
Revenue growth 5Y3.26%
Sales Q2Q%4.83%
Revenue Next Year16.21%
Revenue Next 2Y22.69%
Revenue Next 3Y20.14%
Revenue Next 5Y17.18%
EBIT growth 1Y49.35%
EBIT growth 3Y7.6%
EBIT growth 5Y-0.07%
EBIT Next Year29.05%
EBIT Next 3Y28.76%
EBIT Next 5Y15.68%
FCF growth 1Y-10.12%
FCF growth 3Y28.08%
FCF growth 5Y168.82%
OCF growth 1Y-12.3%
OCF growth 3Y27.97%
OCF growth 5Y145.28%